1. Home
  2. AUPH vs PLYA Comparison

AUPH vs PLYA Comparison

Compare AUPH & PLYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • PLYA
  • Stock Information
  • Founded
  • AUPH 1993
  • PLYA 2006
  • Country
  • AUPH Canada
  • PLYA Netherlands
  • Employees
  • AUPH N/A
  • PLYA N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • PLYA Hotels/Resorts
  • Sector
  • AUPH Health Care
  • PLYA Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • PLYA Nasdaq
  • Market Cap
  • AUPH 1.0B
  • PLYA 1.0B
  • IPO Year
  • AUPH 1999
  • PLYA N/A
  • Fundamental
  • Price
  • AUPH $8.20
  • PLYA $9.71
  • Analyst Decision
  • AUPH Strong Buy
  • PLYA Strong Buy
  • Analyst Count
  • AUPH 3
  • PLYA 5
  • Target Price
  • AUPH $10.33
  • PLYA $11.40
  • AVG Volume (30 Days)
  • AUPH 1.2M
  • PLYA 1.1M
  • Earning Date
  • AUPH 11-07-2024
  • PLYA 11-06-2024
  • Dividend Yield
  • AUPH N/A
  • PLYA N/A
  • EPS Growth
  • AUPH N/A
  • PLYA 106.66
  • EPS
  • AUPH N/A
  • PLYA 0.49
  • Revenue
  • AUPH $220,361,000.00
  • PLYA $949,669,000.00
  • Revenue This Year
  • AUPH $36.52
  • PLYA N/A
  • Revenue Next Year
  • AUPH $19.02
  • PLYA $2.21
  • P/E Ratio
  • AUPH N/A
  • PLYA $20.12
  • Revenue Growth
  • AUPH 38.72
  • PLYA 0.71
  • 52 Week Low
  • AUPH $4.71
  • PLYA $6.95
  • 52 Week High
  • AUPH $10.05
  • PLYA $10.13
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 72.16
  • PLYA 74.17
  • Support Level
  • AUPH $7.03
  • PLYA $8.49
  • Resistance Level
  • AUPH $8.70
  • PLYA $10.13
  • Average True Range (ATR)
  • AUPH 0.30
  • PLYA 0.24
  • MACD
  • AUPH 0.13
  • PLYA 0.11
  • Stochastic Oscillator
  • AUPH 80.00
  • PLYA 77.38

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About PLYA Playa Hotels & Resorts N.V.

Playa Hotels & Resorts NV acts as an owner, operator, and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. The company's segments are Yucatan Peninsula, Pacific Coast, Dominican Republic, and Jamaica. It generates a majority of its revenue from the Yucatan Peninsula segment. Its brand profile consists of HYATT ZIVA, HYATT ZILARA, Hilton, JEWEL RESORTS, and others.

Share on Social Networks: